Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
1 clinical trials · Condition
◉ Watch Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
| Record | Firm | Date |
|---|---|---|
| Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP (NCT07354074) | Novartis Pharmaceuticals | 2026-04-28 |
Track Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive automatically
Every clearance here is in the API, with alerts when new ones post.